Bill > A3941

Introduced Session

This bill would establish, in the Department of the Treasury, a dedicated, non-lapsing fund to be known as the "Opioid Settlement Treatment Support Fund." The State Treasurer will be required to deposit into the fund any moneys that are allocated to or otherwise received by the State as a result of a settlement agreement entered into, or litigation undertaken against, opioid manufacturers and distributors. Any interest and other income earned on moneys in the fund, and any other moneys that may be appropriated or otherwise become available for purposes of the fund, are to be credited to and deposited in the fund. Moneys in the fund are to be dedicated and used only for the purposes of financing, expanding, enhancing, and modernizing substance use disorder prevention and treatment programs and services in the State, particularly those programs and services that focus on: 1) the prevention or treatment of opioid use disorders; or 2) the prevention or treatment of opioid and other substance use disorders occurring in members of particularly vulnerable populations or groups of individuals, including, but not limited to, inmates, parolees, and probationers; persons who have both a substance use disorder and a co-occurring mental illness; and persons who are socially or physically isolated, whether as a result of the COVID-19 pandemic or for any other reason. The bill provides for the Legislature to annually appropriate moneys in the fund to the Department of Human Services, which will be required to allocate the appropriated funds to the Division of Mental Health and Addiction Services and the Office of Licensing in the department, and to community-based service providers through the issuance of grants, as may be deemed by the Commissioner of Human Services to be necessary and appropriate to effectuate the purposes specified by the bill. It is becoming clear that the State of New Jersey will receive a significant amount of settlement dollars from litigation that has been undertaken against opioid manufacturers and distributors for their contributions to the State and nation's opioid epidemic, and it is important that these settlement dollars be dedicated to reducing or mitigating the effects of opioid addiction in the State. In the 1990s, four of the largest tobacco companies entered into a settlement agreement with 46 states that had filed more than 800 claims against them. In many of those states, however, moneys received from the settlement were not used to reduce or eliminate tobacco usage, but were instead used for law enforcement purposes, deficit reduction, or for bolstering the states' general funds. Tobacco usage, meanwhile, continues to cause problems both for individuals and for society as a whole. Despite the success of recent lawsuits against opioid manufacturers and distributors, the opioid epidemic continues to ravage the State and nation's communities, and the societal harms caused thereby continue to be great. Although the Department of Human Services provides numerous programs and services to prevent opioid overdoses and aid in the treatment of opioid dependency and addiction in the State, and although numerous non-profit community-based services are also available throughout the State to assist and provide treatment and recovery services to persons with opioid use disorders; sufficient funding is needed to support and expand these programs and ensure that appropriate substance use disorder treatment services are available throughout the State to all who need them. The COVID-19 pandemic, moreover, which was declared by the World Health Organization in March 2020, has resulted in the significant lock-down of society and the imposition of new social distancing rules throughout the State and nation. This has made it much harder to reach and provide effective treatment and recovery services to persons who have opioid and other substance use disorders, and it has additionally reduced the social support network that is available to individuals who are currently in treatment for, or are recovering from, opioid dependence or addiction. Because it is not clear when the COVID-19 pandemic will subside, and it is possible that the disease will be present in society on a long-term basis, there is an urgent need, now more than ever, to sustain and increase funding for the State agencies and community providers that are continuing to provide substance use disorder treatment services in these uncertain and changing times.

AI Summary

Committee Categories

Daniel Benson (D)*,  Valerie Vainieri Huttle (D)*, 

Introduced, Referred to Assembly Health Committee (on 04/13/2020)